Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial
Sham Mailankody(Memorial Sloan Kettering Cancer Center), Eric L. Smith(Dana-Farber Cancer Institute), Oscar Lahoud(Memorial Sloan Kettering Cancer Center), Analisa Wills(Memorial Sloan Kettering Cancer Center), John Pineda(National Supercomputing Center in Wuxi), Yvette Bernal(Memorial Sloan Kettering Cancer Center), Terence J. Purdon(Memorial Sloan Kettering Cancer Center), Malin Hultcrantz(United States Fish and Wildlife Service), Qi Gao(Memorial Sloan Kettering Cancer Center), Pavan Anant(Memorial Sloan Kettering Cancer Center), Gunjan L. Shah(Cornell University), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Nikoletta Lendvai(Centro de Investigación del Cáncer), Alexander M. Lesokhin(Memorial Sloan Kettering Cancer Center), Claudia Diamonte(Memorial Sloan Kettering Cancer Center), Craig S. Sauter(Memorial Sloan Kettering Cancer Center), Arnab Ghosh(Memorial Sloan Kettering Cancer Center), Isabelle Rivière(Memorial Sloan Kettering Cancer Center), Carlos Fernández de Larrea(Hospital Clínic de Barcelona), Michael Scordo(Cornell University), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), David J. Chung(Memorial Sloan Kettering Cancer Center), Hani Hassoun(Memorial Sloan Kettering Cancer Center), Neha Korde(United States Fish and Wildlife Service), Brigitte Sénéchal(Memorial Sloan Kettering Cancer Center), Mette Stæhr(Memorial Sloan Kettering Cancer Center), Renier J. Brentjens(Roswell Park Comprehensive Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Pallavi Khattar(Memorial Sloan Kettering Cancer Center), Elizabeth Halton(Memorial Sloan Kettering Cancer Center), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Ola Landgren(University of Miami Health System), Xiuyan Wang(Memorial Sloan Kettering Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Heather Landau(Memorial Sloan Kettering Cancer Center), Maria Lia Palomba(Memorial Sloan Kettering Cancer Center), Achim A. Jungbluth(Gynecologic Oncology Group)
Cited by 100
Related Papers
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k